Zimmer Biomet Holdings, Inc., commonly referred to as Zimmer Biomet, is a leading global medical device company headquartered in the United States. Founded in 1927, the company has established itself as a key player in the orthopaedics and musculoskeletal health industry, with a strong presence in North America, Europe, and Asia-Pacific. Zimmer Biomet specialises in the design, manufacture, and marketing of innovative products for joint reconstruction, trauma, spine, and dental applications. Their core offerings, including advanced surgical instruments and biologics, are distinguished by their commitment to enhancing patient outcomes and improving surgical efficiency. With a robust portfolio and a reputation for quality, Zimmer Biomet has achieved significant milestones, positioning itself as a trusted partner in healthcare. The company continues to lead the market through ongoing innovation and a focus on patient-centric solutions.
How does Zimmer Biomet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zimmer Biomet's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zimmer Biomet, headquartered in the US, currently does not provide specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not outlined any formal reduction targets or climate pledges. This lack of publicly available data suggests that Zimmer Biomet may still be in the early stages of developing its climate commitments or reporting frameworks. As the medical device industry increasingly prioritises sustainability, Zimmer Biomet's future initiatives may align with broader industry trends towards reducing carbon footprints and enhancing environmental responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zimmer Biomet has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
